Landesman KA et al. |
Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. |
1999 |
Conn Med |
pmid:10500341
|
Gómez G et al. |
Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin. |
1999 |
Transplant. Proc. |
pmid:10500563
|
Unge P |
The OAC and OMC options. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503817
|
Spiller RC |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503819
|
Mégraud F |
Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503821
|
Bazzoli F et al. |
What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503822
|
Gisbert JP et al. |
Re-treatment after Helicobacter pylori eradication failure. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503846
|
Uygun A et al. |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. |
1999 |
Clin Ther |
pmid:10509849
|
McMullin ST et al. |
Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. |
1999 |
Arch. Intern. Med. |
pmid:10510994
|
Furuta T et al. |
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10511062
|
Galil K et al. |
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. |
1999 Sep-Oct |
Emerging Infect. Dis. |
pmid:10511524
|
Talley NJ et al. |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. |
1999 |
N. Engl. J. Med. |
pmid:10511608
|
Gilljam M et al. |
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. |
1999 |
Eur. Respir. J. |
pmid:10515412
|
Rovira E et al. |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. |
1999 |
Respiration |
pmid:10516537
|
Foster SF et al. |
Chronic pneumonia caused by Mycobacterium thermoresistibile in a cat. |
1999 |
J Small Anim Pract |
pmid:10516950
|
Goldberg EI et al. |
Henoch-Schönlein purpura induced by clarithromycin. |
1999 |
Int. J. Dermatol. |
pmid:10517691
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Gibson JR et al. |
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. |
1999 |
J. Clin. Microbiol. |
pmid:10523591
|
Baylor P and Williams K |
Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10525003
|
Yoh M et al. |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. |
1999 |
Can. J. Microbiol. |
pmid:10526400
|